The MaxDiscovery™ Respiratory Syncytial Virus (RSV) ELISA Kit is an enzyme immunoassay designed for research use only that quantifies Respiratory Syncytial Virus or RSV from cells or fluid samples. Respiratory Syncytial Virus is a very common virus that leads to mild, cold-like symptoms in adults and older healthy children. Most otherwise healthy people recover from RSV infection in 1 to 2 weeks. However, infection can be severe in some people, such as certain infants, young children, and older adults. In fact, RSV is the most common cause of bronchiolitis (inflammation of the small airways in the lung) and pneumonia in children under 1 year of age in the United States. Like most ELISA assays, the MaxDiscovery™ Respiratory Syncytial Virus ELISA Kit relies on a Horseradish Perioxidase (HRP) conjugated antibody and the TMB (3,3´,5,5´-tetramethylbenzidine) substrate. TMB is a chromogen that is blue when oxidized with hydrogen peroxide (catalyzed by HRP) and has major absorbance peaks at 370 nm and 652 nm. The color changes to yellow with the addition of acid and has a maximum absorbance at 450 nm. The relative amount of Respiratory Syncytial Virus protein is directly proportional to the optical density (OD) reading at 450 nm. This kit contains materials for the quantitative detection of the RSV protein in human cells or fluid samples. Note: This kit is designed for research use only. All US orders require that a "Research Use Only" certification form (download below) must be filled out and submitted with your order.
Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Natural Protein Points to New Inflammation Treatment Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis.Enzyme Links Age-Related Inflammation, Cancer Researchers have shown that an enzyme key to regulating gene expression -- and also an oncogene when mutated -- is critical for the expression of numerous inflammatory compounds that have been implicated in age-related increases in cancer and tissue degeneration. New Biomarker to Assess Stem Cells Developed A research team led by scientists from UCL have found a way to assess the viability of 'manufactured' stem cells known as induced pluripotent stem cells (iPSCs). The team's discovery offers a new way to fast-track screening methods used in stem cell research.Therapy Halts Progression of Lou Gehrig’s Disease Researchers at Oregon State University announced today that they have essentially stopped the progression of amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, for nearly two years in one type of mouse model used to study the disease – allowing the mice to approach their normal lifespan.Crouching Protein, Hidden Enzyme A new study led by scientists at The Scripps Research Institute (TSRI) and the University of California (UC), Berkeley shows how a crucial molecular enzyme starts in a tucked-in somersault position and flips out when it encounters the right target.HIV Protein Manipulates Hundreds of Human Genes Findings search for new or improved treatments for patients with AIDS.First 3-D Vision of Cancer Target This basic research set the grounds for structure-based drug design approaches that could be beneficial for cancer treatments' - Dr. Cyril Dominguez, University of Leicester.New Light Shed on Genetic Regulation A team of scientists has uncovered greater intricacy in protein signaling than was previously understood, shedding new light on the nature of genetic production.Hacking the Programs of Cancer Stem Cells All tumor cells are the offspring of a single, aberrant cell, but they are not all alike.